Effect of Communicating Structured Benefit and Harm Information in European Patient Leaflets on Individuals' Expectations About Medicines

Conditions

• Cancer

Interventions

• OTHER: Patient leaflet with the EMA's proposed key information section including qualitative statements.
• OTHER: Control (standard patient leaflet)
• OTHER: Patient leaflet with a key information section providing both qualitative and quantitative information on drug benefits and harms.

Sponsor

London School of Economics and Political Science

Collaborators

• [object Object]